$3.37
$0.00 (0.00%)
End-of-day quote: 05/17/2024
NasdaqGM:HBIO
Harvard Bioscience Annual Report
| Year | Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2007 | 2005 | 2004 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$112.25M | $113.34M | $118.90M | $102.10M | $116.18M | $120.77M | $77.41M | $104.52M | $108.66M | $108.66M | $105.17M | $111.17M | $108.86M | $108.18M | $83.41M | $67.43M | $64.75M | |
| GM % | Gross Margin % |
|
59.15% | 54.96% | 56.90% | 56.85% | 55.57% | 55.46% | 50.60% | 46.32% | 44.84% | 45.41% | 45.35% | 47.08% | 46.11% | 47.96% | 48.25% | 49.35% | 49.01% | |
| OM | Operating Margin |
|
2.22% | -4.58% | 1.74% | 0.22% | 1.78% | 3.96% | -0.82% | -1.09% | -0.85% | 6.29% | 5.45% | 7.95% | 8.30% | 9.98% | 11.43% | 12.20% | 13.41% | |
| EPS | Earnings Per Share |
|
$0.00 | $0.14 | $0.12 | $0.25 | $0.16 | $0.18 | $0.20 | $0.12 | $0.15 | $0.13 | $0.27 | $0.02 | $0.22 | $0.28 | $0.36 | $0.31 | $0.19 | $0.17 |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Sha. | Shares |
|
43.39m | 42.08m | 41.14m | 39.41m | 38.19m | 37.38m | 35.02m | 34.44m | 33.98m | 32.56m | 31.64m | 29.38m | 28.54m | 28.31m | 30.85m | 30.48m | 30.39m | |
| OCF | Operating Cash Flow |
|
$14.03M | $1.15M | $1.26M | $9.33M | $8.05M | $2.88M | $1.06M | $5.38M | $0.71M | $4.35M | $4.06M | $8.06M | $6.65M | $12.29M | $12.06M | $5.20M | $11.44M | |
| FCF | Free Cash Flow |
|
$12.60M | $-0.44M | $0.07M | $8.18M | $6.83M | $1.36M | $0.17M | $3.94M | $-2.26M | $2.35M | $2.44M | $6.29M | $5.14M | $11.45M | $10.61M | $4.10M | $8.43M | |
| FCFS | Free Cash Flow Per Share |
|
$0.28 | $-0.01 | $-0.00 | $0.21 | $0.18 | $0.05 | $0.00 | $0.12 | $-0.07 | $0.07 | $0.08 | $0.22 | $0.18 | $0.40 | $0.35 | $0.13 | $0.28 |
